Europe opens doors to supply CBD isolate from Colombia
The European market for hemp pharmaceuticals in Europe, using fairly cheap supplies of CBD isolate from Colombia, is steadily expanding the production of medical (pharmaceutical) drugs, which will be sold both in Europe and in other countries with less liberal legislation regarding manufacturers of hemp products with high added cost, among which so far is Ukraine.
The pages of the profile electronic publication of Ukrainian hemp breeder , which is an integral part of the Ukrainian Technical Cannabis Association, described how “ Colombia will export high-CBD technical hemp in the UK ”. This material attempts to conclude which factor is the basis for the active export of Colombian CBD isolate to the European market and what this trend may indicate.
PharmaCielo, a Colombian manufacturer of cannabis with Canadian roots, has discovered the European market with all its consumer potential. The deal was made with Creso Pharma, a European food manufacturer, based in Switzerland and producing hemp products for both human and veterinary use. The first deliveries of CBD isolate became possible after the Colombian government granted permission to export derivatives of hemp plant processing, thereby strengthening its position as an exporter of hemp products in demand on the European market.
David Attard, CEO of PharmaCielo, said the first shipments are symbolic in many ways. He focuses on the fact that "PharmaCielo is the first medical company actively working with hemp products, and which carries out the commercial export of CBD isolates from Colombia to Switzerland. Also, PharmaCielo does not hide the merger with Creso Pharma, which will ultimately strengthen its position Colombian hemp isolate production on the European continent PharmaCielo, listed on TSX Canada's venture capital market, operates in other countries in South America, as well as Italy, Canada, and Mexico.
Commentary of the Ukrainian Technical Hemp Association
Colombia is becoming one of the suppliers of hemp isolate to the European market, as it has extremely favorable conditions for the growth of the domestic market and cheap labor. Neighboring countries such as Uruguay, Paraguay, Bolivia and Brazil are actively cooperating with PharmaCielo and are trying to jointly develop hemp export to the economically developed countries of the world.
The European market for hemp pharmaceuticals in Europe, using fairly cheap supplies of CBD isolate from Colombia, is steadily expanding the production of medical (pharmaceutical) drugs, which will be sold both in Europe and in other countries with less liberal legislation regarding manufacturers of hemp products with high added cost, among which so far is Ukraine.
CBD Isolate is a prefabricated cannabidiol. To produce an isolate, CBD is isolated and then purified, removing any additional cannabinoids, terpenes, finols, flavonoids, other therapeutic constituents, as well as plant components that are present in the hemp plant. The final product is a fine white powder that contains about 99% cannabidiol. Isolates contain only one therapeutic element of the plant - in most registered products - CBD. Those. CBD isolate does not contain psychoactive tetrahydrocannabinol (THC), which makes it a good option for those looking for products without THC. The CBD isolate has no taste or smell and can be used to prepare a significant number of varieties of CBD products. Since the CBD isolate has a purity of about 99%, it is possible to control the amount of CBD added to the product as accurately as possible.